Premium
Serum Dihydrotestosterone in Patients with Benign Prostatic Hypertrophy
Author(s) -
GHANADIAN R.,
LEWIS J. G.,
CHISHOLM G. D.,
O'DONOGHUE E. P. N.
Publication year - 1977
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1111/j.1464-410x.1977.tb04202.x
Subject(s) - medicine , unit (ring theory) , urology , dihydrotestosterone , prostate , medical school , original research , library science , androgen , psychology , medical education , computer science , cancer , hormone , mathematics education
Serum dihydrotestosterone (DHT) and testosterone were measured by radioimmunoassay in 24 normal men aged 60 to 80 years and in 25 patients with benign prostatic hypertrophy in the same age range. There was a significant increase in the level of dihydrotestosterone in patients with prostatic hypertrophy but no significant difference was found between the testosterone levels of the 2 groups. The scatter of the individual values for DHT indicated that this measurement has little practical clinical application in the diagnosis of prostatic hypertrophy. It is suggested that the increase in DHT may be due, at least in part, to a prostatic contribution to the circulating level and the relevance of this observation in relation to the aetiology of benign prostatic hypertrophy is discussed.